ICD-10 Coding for Cervical Mass(C53.9, C53.9B, C53.9M)
Comprehensive guide to ICD-10 coding for cervical mass, including documentation requirements, common pitfalls, and clinical validation criteria.
Complete code families applicable to Cervical Mass
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R87.619 | Unspecified abnormal cytological findings in specimens from cervix uteri | Use when a cervical mass is identified but not yet histologically confirmed. |
|
| D06.9 | Carcinoma in situ of cervix, unspecified | Use when biopsy confirms CIN III or carcinoma in situ. |
|
| C53.9 | Malignant neoplasm of cervix uteri, unspecified | Use when biopsy confirms invasive cervical cancer. |
|
| N88.8 | Other specified noninflammatory disorders of cervix uteri | Use for benign cervical polyps confirmed by biopsy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutCervical Mass
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Cervical Mass.
Not specifying laterality
Impact
Clinical: May affect treatment decisions, Regulatory: Non-compliance with documentation standards, Financial: Potential claim denials
Mitigation
Always document the side of the cervix affected, Use templates to ensure completeness
Using R87.619 for confirmed neoplasms
Impact
Reimbursement: Incorrect coding may lead to denied claims, Compliance: Non-compliance with coding standards, Data Quality: Inaccurate clinical data reporting
Mitigation
Upgrade to D06 or C53 based on histology
Histology Confirmation
Impact
Risk of coding errors without biopsy confirmation
Mitigation
Require biopsy results before finalizing codes